The financial burden of cancer treatment is a well-established concern.
1,2 Owing to cost sharing, even insured patients face financial burden and are at risk for worsened quality of life
3 and increased mortality.
4 Underinsured patients (those spending more than 10% of their income on health care costs) are a growing population,
5 and are at risk given the looming heath policy and coverage changes on the horizon. In this setting, little is known about what expectations patients have regarding those costs and how those cost expectations might impact decision making.